Multiple pathogen antigen

"Multiple pathogen antigens" is not a single, specific molecular target but rather a broad term that refers to the variety of **antigenic molecules present on or produced by different pathogenic microorganisms** (such as bacteria, viruses, fungi, or parasites). Antigens are any molecules—commonly proteins, carbohydrates, or nucleic acids—originating from pathogens that can be recognized by the immune system and trigger an immune response, such as the activation of B cells and T cells[1][3][6][5]. Because each pathogen carries or secretes many different antigens, the phrase "multiple pathogen antigens" lacks specificity: it does not correspond to a singular molecular entity, protein, or gene, but to a highly diverse group of molecules[2]. This term is too generic for structured drug target information. In therapeutic development, precise targeting is necessary, often aimed at a well-defined antigen or epitope from a particular pathogen—for example, "SARS-CoV-2 spike glycoprotein" rather than "multiple pathogen antigens"[2][5][6]. Therefore, "multiple pathogen antigens" is an imprecise and non-standard entry for use as a canonical drug target name.